Literature DB >> 11348721

Storage at -3 degrees C for 24 h alters the immunogenicity of pertussis vaccines.

C A Boros1, M Hanlon, M S Gold, D M Roberton.   

Abstract

The immunogenicity of pertussis antigens in an acellular and a whole-cell triple antigen vaccine used for childhood immunisation was assessed in murine models after storage of vaccines below 0 degree C. Swiss outbred and Balb/c mice received DTPa or DTPw vaccine or placebo. Vaccines were stored at 2-8 degrees C (ideal), or at -3 degrees C for 24 h. Pre and post immunisation IgG responses to pertussis toxin (PT), filamentous haemagglutinin (FHA) and pertactin (PRN) were measured using enzyme immunoassays (EIA). In Balb/c mice, responses to pertactin after receiving adversely stored DTPa were significantly reduced (P = 0.005, difference in GMCs 145.9% [24.6-385.4%]). A reduction in GMC to pertactin was also seen in response to adversely stored DTPw (P = 0.190,224.1% [83.8-599.2%]). Outbred mice receiving adversely stored DTPa had lower IgG antibody responses to FHA than those receiving correctly stored vaccine (P = 0.002,522.2% [26.1-2155.6%]). Outbred mice also had a significantly lower response to FHA after administration of DTPw (P = 0.009,14.0% [3.8-51.9%]). Responses to DTPa in both strains generally were greater than those to DTPw. Storage of pertussis vaccines below 0 degree C appears to alter the immunogenicity of PRN and FHA. Further study is required to determine the effects of such storage on vaccine protective efficacy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11348721     DOI: 10.1016/s0264-410x(01)00063-9

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  Graphic-output temperature data loggers for monitoring vaccine refrigeration: implications for pertussis.

Authors:  Patrick McColloster; Carlos Vallbona
Journal:  Am J Public Health       Date:  2010-11-18       Impact factor: 9.308

2.  Frequent exposure to suboptimal temperatures in vaccine cold-chain system in India: results of temperature monitoring in 10 states.

Authors:  Manoj V Murhekar; Srihari Dutta; Ambujam Nair Kapoor; Sailaja Bitragunta; Raja Dodum; Pramit Ghosh; Karumanagounder Kolanda Swamy; Kalyanranjan Mukhopadhyay; Somorjit Ningombam; Kamlesh Parmar; Devegowda Ravishankar; Balraj Singh; Varsha Singh; Rajesh Sisodiya; Ramaratnam Subramanian; Tana Takum
Journal:  Bull World Health Organ       Date:  2013-09-09       Impact factor: 9.408

3.  Effect of freezing on recombinant hepatitis E vaccine.

Authors:  Kelei Li; Fangyu Dong; Fan Gao; Lianlian Bian; Shiyang Sun; Ruixiao Du; Yalin Hu; Qunying Mao; Haifa Zheng; Xing Wu; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2019-12-06       Impact factor: 3.452

Review 4.  Advances in aluminum hydroxide-based adjuvant research and its mechanism.

Authors:  Peng He; Yening Zou; Zhongyu Hu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

5.  The immunogenicity of thin-film freeze-dried, aluminum salt-adjuvanted vaccine when exposed to different temperatures.

Authors:  Sachin G Thakkar; Tinashe B Ruwona; Robert O Williams; Zhengrong Cui
Journal:  Hum Vaccin Immunother       Date:  2017-01-04       Impact factor: 3.452

6.  Evaluation of temperature stability among different types and grades of vaccine storage units: Data from continuous temperature monitoring devices.

Authors:  Andrew J Leidner; Helen Fisun; Sean Trimble; Paul Lucas; Cameron Noblit; John M Stevenson
Journal:  Vaccine       Date:  2020-02-25       Impact factor: 3.641

7.  Reducing the loss of vaccines from accidental freezing in the cold chain: the experience of continuous temperature monitoring in Tunisia.

Authors:  John Lloyd; Patrick Lydon; Ramzi Ouhichi; Michel Zaffran
Journal:  Vaccine       Date:  2014-11-08       Impact factor: 3.641

8.  Good vaccination practice: it all starts with a good vaccine storage temperature.

Authors:  Frédéric Vangroenweghe
Journal:  Porcine Health Manag       Date:  2017-12-04

9.  Stability of an aluminum salt-adjuvanted protein D-conjugated pneumococcal vaccine after exposure to subzero temperatures.

Authors:  Juliette Fortpied; Florence Wauters; Christelle Rochart; Philippe Hermand; Bernard Hoet; Nicolas Moniotte; Ivo Vojtek
Journal:  Hum Vaccin Immunother       Date:  2018-02-12       Impact factor: 3.452

10.  Stability of a monovalent rotavirus vaccine after exposure to different temperatures observed in KwaZulu-Natal, South Africa.

Authors:  Osaretin Emmanuel Asowata; Olubisi Titilayo Ashiru; A Willem Sturm; Prashini Moodley
Journal:  Afr Health Sci       Date:  2019-06       Impact factor: 0.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.